Skip to main content
. 2018 Nov 28;13:2425–2441. doi: 10.2147/CIA.S182881

Table 7.

Results of multivariate analyses for reduced sodium intake subscale of the Hill-Bone CHBPTS

Variables Coefficient 95% CI P-value
Age (years) −0.01 −0.04 0.03 0.78
SBP (mmHg) 0.00 −0.01 0.02 0.87
DBP (mmHg) −0.02 −0.04 0.00 0.02
BMI (kg/m2) 0.02 −0.02 0.05 0.35
Duration of disease (years) 0.01 −0.02 0.03 0.56
Sex
 Female=0
 Male=1 0.36 −0.02 0.75 0.07
Marital status
 Single, divorced, or widowed=0
 Married or living together=1 −0.46 −1.02 0.10 0.11
Education
 Primary or none=1
 Secondary, vocational or higher=1 −0.31 −0.76 0.14 0.18
Occupational activity
 Employed or annuitant=0
 Retired=1 −0.44 −0.84 −0.04 0.03
Living arrangement
 Living alone or in an organized institution=0
 Living with family=1 0.34 −0.17 0.85 0.19
JNC classification of HT
 Prehypertension=0
 Stage I or II HT=1 0.44 −0.05 0.93 0.08
Smoking
 Non-smoker=0
 Smoker or ex-smoker=1 −0.18 −0.61 0.25 0.42
Alcohol
 Abstinent=0
 Non-abstinent=1 0.29 −0.14 0.71 0.19
Diabetes
 No=0
 Yes=1 0.34 −0.04 0.72 0.08
Hypercholesterolemia
 No=0
 Yes=1 0.27 −0.14 0.68 0.19
Coronary artery disease
 No=0
 Yes=1 0.17 −0.31 0.65 0.49
Renal failure
 No=0
 Yes=1 −0.18 −0.74 0.38 0.53
Rheumatic diseases
 No=0
 Yes=1 0.13 −0.37 0.63 0.61
Alpha-adrenolytic
 No=0
 Yes=1 −0.01 −0.48 0.46 0.97
BA
 No=0
 Yes=1 0.26 −0.74 1.25 0.61
CCB
 No=0
 Yes=1 0.27 −0.22 0.77 0.28
ARB
 No=0
 Yes=1 0.52 −0.04 1.09 0.07
TD
 No=0
 Yes=1 0.23 −0.68 1.14 0.62
ACEI
 No=0
 Yes=1 0.65 0.11 1.20 0.02
Therapy
 Monotherapy=0
 Polytherapy=1 0.10 −0.46 0.67 0.72

Note: P, level of statistical significance.

Abbreviations: AA, alpha-adrenolytic; ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; BA, beta-adrenolytic; BMI, body mass index; CCB, calcium channel blocker; Hill-Bone CHBPTS, Hill-Bone Compliance to High Blood Pressure Therapy Scale; HT, hypertension; JNC, Joint National Committee; TD, thiazide diuretic.